
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128118 |
drug action
Tocainide Sodium Channel Cardiac Muscle Relaxation Action PathwayHomo sapiens
Tocainide is an orally active class 1b antiarrhythmic agent that interferes with cardiac sodium channels and typically used to treat ventricular arrhythmias. It is used to treat conditions including sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.Tocainide binds preferentially to the inactive state of the sodium channels. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers. It also possesses some anticholinergic and local anesthetic properties. Side effects of tocainide include nausea, vomiting, headaches, feeling dizzy, or feeling hot and flushed.
|
Creator: Hayley Created On: July 19, 2023 at 14:51 Last Updated: July 19, 2023 at 14:51 |
PW146412 |
drug action
Tocofersolan Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:08 Last Updated: October 07, 2023 at 18:08 |
PW146319 |
drug action
Tocopherol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:55 Last Updated: October 07, 2023 at 17:55 |
PW145874 |
drug action
Tofacitinib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:52 Last Updated: October 07, 2023 at 16:52 |
PW176479 |
Tofacitinib Predicted Metabolism PathwayHomo sapiens
Metabolites of Tofacitinib are predicted with biotransformer.
|
Creator: Omolola Created On: December 12, 2023 at 16:21 Last Updated: December 12, 2023 at 16:21 |
PW127726 |
drug action
Tolazamide Action PathwayHomo sapiens
Tolazamide is an hypoglycemic agent from the sulfonylurea class used in the treatment of non insulin dependent diabetes mellitus type II. Tolazamide lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. This drug binds to ATP-sensitive potassium-channel receptors on the pancreatic cell surface (known as the sulfonylurea receptor 1 (SUR1) subunit (Kir6.2)), reducing potassium conductance and causing depolarization of the membrane. This depolarization stimulates the calcium ion influx through voltage-sensitive calcium channels thus raising intracellular concentrations of calcium ions. The higher concentration of intracellular calcium ions induces the secretion (exocytosis) of insulin into the blood. Tolazamide is administered as an oral tablet.
|
Creator: Daphnee Created On: May 26, 2023 at 12:05 Last Updated: May 26, 2023 at 12:05 |
PW144944 |
drug action
Tolazamide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:46 Last Updated: October 07, 2023 at 14:46 |
PW176149 |
Tolazamide Predicted Metabolism Pathway newHomo sapiens
Metabolites of Tolazamide are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:20 Last Updated: November 29, 2023 at 14:20 |
PW132365 |
Tolazoline Drug MetabolismHomo sapiens
Tolazoline is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Tolazoline passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 21:14 Last Updated: September 21, 2023 at 21:14 |
PW144904 |
drug action
Tolazoline Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:40 Last Updated: October 07, 2023 at 14:40 |